ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 74 filers reported holding ACELRX PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $815,000 | -59.4% | 264,900 | -49.2% | 0.08% | -68.0% |
| Q4 2015 | $2,008,000 | +104.9% | 521,700 | +63.8% | 0.26% | +101.6% |
| Q3 2015 | $980,000 | +351.6% | 318,500 | +464.7% | 0.13% | +323.3% |
| Q1 2015 | $217,000 | -1.8% | 56,400 | +173.8% | 0.03% | -41.2% |
| Q3 2013 | $221,000 | -77.0% | 20,600 | -80.1% | 0.05% | -80.2% |
| Q2 2013 | $962,000 | – | 103,700 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,528,120 | $38,210,000 | 1.53% |
| Cormorant Asset Management, LP | 850,000 | $2,593,000 | 0.41% |
| Palo Alto Investors LP | 1,656,644 | $5,053,000 | 0.24% |
| Granahan Investment Management | 1,745,604 | $5,324,000 | 0.16% |
| Spark Investment Management LLC | 318,500 | $980,000 | 0.13% |
| Opus Point Partners Management, LLC | 57,747 | $176,000 | 0.10% |
| SHEPHERD KAPLAN KROCHUK, LLC | 76,472 | $233,000 | 0.06% |
| Joel Isaacson & Co., LLC | 70,660 | $216,000 | 0.06% |
| MYCIO WEALTH PARTNERS, LLC | 75,000 | $229,000 | 0.05% |
| Cornerstone Capital, Inc. | 59,200 | $181,000 | 0.04% |